NCT02890069 2023-01-11A Study of PDR001 in Combination With LCL161, Everolimus or PanobinostatNovartisPhase 1 Completed298 enrolled
NCT00550277 2021-11-23LBH589 Treatment for Refractory Clear Cell Renal CarcinomaSCRI Development Innovations, LLCPhase 2 Completed20 enrolled 7 charts